↓ Skip to main content

A Retrospective Metabolomics Analysis of Gamma-Hydroxybutyrate in Humans: New Potential Markers and Changes in Metabolism Related to GHB Consumption

Overview of attention for article published in Frontiers in Pharmacology, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Retrospective Metabolomics Analysis of Gamma-Hydroxybutyrate in Humans: New Potential Markers and Changes in Metabolism Related to GHB Consumption
Published in
Frontiers in Pharmacology, March 2022
DOI 10.3389/fphar.2022.816376
Pubmed ID
Authors

Tingting Wang, Kirstine L. Nielsen, Kim Frisch, Johan K. Lassen, Camilla B. Nielsen, Charlotte U. Andersen, Palle Villesen, Mette F. Andreasen, Jørgen B. Hasselstrøm, Mogens Johannsen

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 17%
Student > Master 2 17%
Student > Bachelor 1 8%
Researcher 1 8%
Professor > Associate Professor 1 8%
Other 0 0%
Unknown 5 42%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 25%
Medicine and Dentistry 2 17%
Environmental Science 1 8%
Unknown 6 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2022.
All research outputs
#18,102,444
of 23,257,423 outputs
Outputs from Frontiers in Pharmacology
#7,349
of 16,694 outputs
Outputs of similar age
#299,882
of 440,932 outputs
Outputs of similar age from Frontiers in Pharmacology
#540
of 1,286 outputs
Altmetric has tracked 23,257,423 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,694 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,932 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,286 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.